DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Huynh H, Ngo VC, Fargnoli J , et al.
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
Clin Cancer Res 2008;
14 (19) 6146-6153
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.